Banking

Mckesson Stock Shows Rising Relative Strength; Still Shy Of Key Threshold

Mckesson (MCK) saw a welcome improvement to its Relative Strength (RS) Rating on Monday, with an upgrade from 68 to 71. Decades of market research reveals that the best-performing stocks often have an 80 or higher RS Rating in the early stages of their moves. See if Mckesson stock can continue to rebound and hit that benchmark.




X



When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.

IBD’s proprietary rating identifies share price performance with a 1 (worst) to 99 (best) score. The rating shows how a stock’s price behavior over the last 52 weeks compares to all the other stocks in our database.


Looking For Winning Stocks? Try This Simple Routine


 

McKesson is an U.S.-based company distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools.

Mckesson Stock Works On A Base

Irving, Texas-based Mckesson is working on a flat base with a 210.10 buy point. See if it can clear the breakout price in heavy volume.

Earnings grew 101% last quarter, up from 18% in the prior report. Revenue also increased, from 1% to 13%.

Mckesson stock earns the No. 1 rank among its peers in the Medical-Wholesale Drugs industry group.

YOU MIGHT ALSO LIKE:

Which Stocks Are Showing Rising Relative Strength?

Why Should You Use IBD’s Relative Strength Rating?

How Relative Strength Line Can Help You Judge A Stock

Identify Bases And Buy Points With Pattern Recognition From MarketSmith

Most Related Links :
Business News Governmental News Finance News

Need Your Help Today. Your $1 can change life.

[charitable_donation_form campaign_id=57167]

Source link

Back to top button